Researchers at the University of Basel have developed a new approach to applying thermodynamics to microscopic quantum systems.
The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation. Researchers at the University of Basel have now discovered that it also fights metastases in certain types of breast cancer.
Our body’s “blood factory” consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this cellular complexity in the laboratory using only human cells. The novel system could reduce the need for animal experiments for many applications.
Marine microorganisms produce large amounts of nitrous oxide, a highly potent greenhouse gas. A Basel-based researcher investigated the exact processes involved during an expedition to the Pacific. The results are important for climate modeling.
State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules. However, researchers at the University of Basel have shown that these programs only memorize patterns, rather than understanding physical relationships.
Once a sperm has broken through to an egg cell in order to fertilise it, the two cells need to hold together tightly. This occurs via a type of protein binding that is among the strongest in biology – and it is also unique.
Why are more and more people in Western democracies yearning for destruction? And why do they vote for parties that promise just that? Literary sociologist Carolin Amlinger unpacks the roots of the global rightward shift and reveals why even Switzerland isn’t immune.
Certain nutrients in food can trigger a mild stress response in nematodes. But instead of making them sick, this actually helps them stay healthier as they age, according to researchers at the University of Basel.
A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel have demonstrated that this fusion protein can both block the “do not attack” signal used by cancer cells and selectively activate tumor-fighting immune cells. This dual action could pave the way for more effective cancer therapies with fewer side effects.
